Global Cerebral Vasospasm Market Research Report, by Diagnosis (Computed
Tomography Angiography, Digital Subtraction Angiography), Treatment
(Nimodipine, Triple-H Therapy, Balloon Angioplasty), End-User (Hospitals,
Clinics)– Global Forecast Till 2023
Global Cerebral Vasospasm Market - Scenario
The advances in medical knowledge are leading to the
breakthroughs being achieved in the treatment of cerebral vasospasm. Reports
that examine the medical device industry has been presented by Market Research
Future, which produces reports on industry verticals that evaluate the market
development and opportunities. The market is expected to gain a CAGR of 5.4 %
in the upcoming period.
Cerebral vasospasm is most commonly observed in patients who
survive subarachnoid hemorrhage. The narrowing of cerebral arteries is termed
as cerebral vasospasm. Narrowing of cerebral artery leads to cerebral ischemia
and then death. Increasing prevalence of subarachnoid hemorrhage and a rise in
the prevalence of traumatic brain injury is the key factor driving the growth
of the market. According to the Centers
for Disease Control and Prevention 2017, 30% of the total injury deaths are due
to traumatic brain injury in the US. Other factors contributing to the growth
of the market are increasing hypertension among the population, rising adoption
of smoking, changing lifestyle, growing geriatric population, increasing
prevalence of bleeding disorders, rising use of blood thinners and the
introduction of technologically advanced treatments.
However, factors such as high cost associated with treatment,
risks associated with drugs and medication and a shortage of skilled
professionals are expected to hinder the market growth during the forecast
period.
Segmentation
Global cerebral
vasospasm market is segmented on the basis of type of treatment which
includes triple-H therapy, nimodipine and other. On the basis of route of
administration the market is segmented into oral, intravenous and
intra-arterial and on the basis of end user the market is again segmented into
hospitals, clinics and others.
Key Players
·
Headsense Medical Ltd (Israel),
·
B. Braun Melsungen AG (Germany),
·
Minnetronix, Inc (US),
·
Bristol-Myers Squibb Company (US),
·
Boehringer Ingelheim GmbH (Germany)
·
H. Lundbeck A/S (Denmark)
Regional Analysis
Geographically, North America has
the largest market of cerebral vasospasm. North America cerebral vasospasm
market is driven by robust research & development practices along with
growing advancements in the field of neurology. Europe has the second largest
market of cerebral vasospasm which is followed by Asia Pacific. In Middle
East and Africa the market is least due to limited development in the
healthcare sector.
The report of global cerebral
vasospasm market by Market Research Future comprises of extensive primary
research along with detail analysis of qualitative as well as quantitative
aspects by various industry experts and key opinion leaders to gain a deeper
insight of the market and industry performance. The report gives a clear
picture of current market scenario which includes past and estimated future
market size with respect to value and volume, technological advancement, macro
economical and governing factors in the market. The report provides detail
information about and strategies used by top key players in the industry. The
report also gives a broad study of the market’s different segments and regions.
Browse more
Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report
No comments:
Post a Comment